IRIS
LAZZARINO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.003
AS - Asia 4.658
EU - Europa 4.052
SA - Sud America 438
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 15.217
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.901
CN - Cina 2.902
SG - Singapore 919
IE - Irlanda 816
UA - Ucraina 806
HK - Hong Kong 531
FI - Finlandia 518
DE - Germania 509
BR - Brasile 360
RU - Federazione Russa 343
SE - Svezia 322
IT - Italia 291
GB - Regno Unito 218
FR - Francia 106
VN - Vietnam 105
CA - Canada 64
IN - India 47
AR - Argentina 31
MX - Messico 28
NL - Olanda 28
JP - Giappone 23
BD - Bangladesh 22
BE - Belgio 22
PL - Polonia 19
TR - Turchia 18
ZA - Sudafrica 18
IQ - Iraq 17
ES - Italia 15
ID - Indonesia 13
VE - Venezuela 11
EC - Ecuador 10
IR - Iran 8
LT - Lituania 8
PY - Paraguay 8
PK - Pakistan 7
AU - Australia 6
IL - Israele 6
KE - Kenya 6
MU - Mauritius 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
EU - Europa 5
JO - Giordania 5
AT - Austria 4
BO - Bolivia 4
CL - Cile 4
PE - Perù 4
RO - Romania 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
MA - Marocco 3
NG - Nigeria 3
PA - Panama 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MN - Mongolia 2
MY - Malesia 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MT - Malta 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.217
Salva come PNG Salva come JPEG
Città #
Jacksonville 957
Chandler 922
Dublin 816
Nanjing 765
Hong Kong 531
Ashburn 407
Dallas 387
Singapore 370
Boardman 346
Beijing 326
Nanchang 294
New York 236
Hebei 213
Princeton 206
Shenyang 204
Lawrence 202
Medford 196
Changsha 186
Wilmington 169
Jiaxing 155
Ann Arbor 141
Los Angeles 123
Tianjin 120
Hangzhou 118
Helsinki 85
Buffalo 81
Milan 72
Redondo Beach 58
Moscow 55
Woodbridge 52
Shanghai 50
Verona 48
Falkenstein 45
Ho Chi Minh City 39
Munich 37
Norwalk 35
São Paulo 32
Turku 29
Seattle 27
Toronto 27
Des Moines 23
Jinan 23
Brooklyn 22
Brussels 22
Tokyo 22
Montreal 20
Hanoi 18
Santa Clara 18
Auburn Hills 17
Kunming 17
Warsaw 17
Zhengzhou 17
Fairfield 16
Ningbo 16
Rome 16
Stockholm 16
Houston 14
Guangzhou 13
San Francisco 13
The Dalles 13
Chicago 12
London 12
Pavia 12
Belo Horizonte 11
Lanzhou 11
Pune 11
Johannesburg 10
Nuremberg 10
Taizhou 10
Ankara 9
Rio de Janeiro 9
Atlanta 8
Secaucus 8
Brasília 7
Chongqing 7
Dalian 7
Frankfurt am Main 7
Mexico City 7
Orange 7
Orem 7
Qingdao 7
Washington 7
Baghdad 6
Boston 6
Columbus 6
Council Bluffs 6
Dearborn 6
Denver 6
Manchester 6
Phoenix 6
Villa Literno 6
Amman 5
Amsterdam 5
Andover 5
Charlotte 5
Curitiba 5
Dhaka 5
Guayaquil 5
Haiphong 5
Istanbul 5
Totale 9.810
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 162
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. 161
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 143
A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implicatios for serologic staging. 132
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 128
A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes 122
Blast phase of essential thrombocythemia: A single center study. 120
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 120
Analisi in citometria a flusso dei pattern differenziativi della leucemia mieloide cronica in crisi blastica. Uno studio immunofenotipico di 26 casi consecutivi 119
Alterazioni Citogenetiche nelle sindromi mielodisplastiche 117
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 115
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 112
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) 112
Splenic nodal and extranodal marginal zone lymphoma: features of bone marrow involvement. 111
Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders 110
Multiple granulocytic sarcoma during complete hematologic remission of acute nonlymphoid leukemia. 109
EFFICACY OF PIPOBROMAN IN THE TREATMENT OF POLYCYTHEMIA VERA: LONG TERM RESULTS IN 163 PATIENTS 107
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. 107
Adult ki-1-positive large cell anaplastic lymphoma presenting with skin lesions. 107
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial 105
Anemia refrattaria con eccesso di blasti : caratteristiche clinico-ematologiche ed implicazioni terapeutiche 105
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. 104
Allogeneic versus autologous BMT versus intensive post-remission chemotherapy in acute leukemias 103
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 102
JAK2 (V617F) mutation in healthy individuals 101
Alterazioni dell’emostasi nelle leucemie e nei tumori solidi 101
ALK+ lymphoma: clinico-pathological findings and outcome. 99
A young woman with microcytic anemia and hypertransaminasemia 97
ABL1 amplification in T-cell acute lymphoblastic leukemia. 96
Citosina arabinoside a basse dosi con o senza 1,25diidrossi vitamina D3 nella terapia delle sindromi mielodisplastiche e nele leucemie acute dell’anziano 95
Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection 93
Central nervous system relapse in acute promyelocytic leucemia 93
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 93
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia 92
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. 90
Outcome of four patients with chronic myeloid leucemia after imatinib mesylate discontinuation. 90
Chemioterapia della leucemia acuta linfoblastica dell’adulto: l’induzione della remissione e la profilassi meningea 90
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. 90
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 90
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 90
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy 89
EFFICACY OF A IDARUBICIN, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE ARABINOSIDE AS SALVAGE THERAPY IN RELAPSING OR RESISTANT UNFAVORABLE LYMPHOMA 89
Pharmacokinetic behavior of Rituximab: a study of different schedules of administration for heterogeneous clinical settings. 89
Valutazione prognostica dele sindromi mielodisplastiche 89
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia 89
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases 87
Treatment of relapsed and refractory acute myloid leukemia in adults 87
Management of nodal diffuse large B-cell lymphomas : practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation 87
Clinical characteristics and outcome of immunoglobulin M-related disorders 86
Ara-c ad alte dosi (HD-Ara-c) per il trattamento della malattia meningea nella leucemia acuta linfoblastica (LAL) e nei Linfomi non Hodgkin (LNH): studio di 25 casi 85
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation 85
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. 84
Primary mediastinal B-cell lymphoma: update of its clinicopathologic features. 84
Lymph node reticulum cell neoplasm with progression into cytokeration-positive interstitial reticulum cell (CIRC) sarcoma: a case study 83
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia 83
Late onset of bortezomib-associated cutaneous reaction following herpes zoster 83
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 83
Etoposide : il citostatico della linea monocitica 83
Incidenza della monosomia 7 in corso di crisi blastica della leucemia mieloide cronica (LMC) Ph1 positiva 83
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. 83
Impiego clinico di agenti antineoplastici ad alte dosi in oncoematologia: methotrexate e citosina arabinoside 82
Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years. 81
Impact of advanced age on the management of acute nonlymphocytic leukemia: a study of 103 patients 81
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 81
Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls 80
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes 80
Le sindromi mielodisplastiche : molteplicita’ degli aspetti ematologici e clinici 80
TREATMENT OF EARLY STAGE HODGKIN’S DISEASE WITH FOUR CYCLES OF ABVD FOLLOWED BY ADJUVANT RADIOTHERAPY: ANALYSIS OF EFFICACY AND LONG TERM TOXICITY 80
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 79
Treatment of Ph1 positive chronic myelogenous leukemia (CML) with recombinant interferon alpha 2b (Intron A) 79
Urinary proteins in multiple myeloma. correlation with clinical parameters and diagnostic implications 78
Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma. 78
Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases 78
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman. 78
A striking response to bortezomib in a patient with pleural localization of multiple myeloma 78
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. 78
Criopreservation of marrow cells for ABMT : is there any effect on the harvested leukemic cell? 78
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. 78
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. 78
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. 78
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity. 77
Long-term outcome of ph-negative acute lymphoblastic leukaemia in adults: a single centre experience. 77
Evolving approaches with alpha interferon in chronic myelogenous leukemia 77
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia 76
Strategie per la mobilizzazione di progenitori emopoietici nel sangue periferico 76
Primary gastric CD30 (Ki-1)positive large cell Non Hodgkin Lymphomas. A clinicopathologic analysis six cases. 76
Interferon alpha2b in the treatment of Ph1 negative myeloproliferative disoders with excessive thrombocytosis 74
Nephrotic sindrome after allogeneic hemopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease 73
Burkitt’s lymphoma/leukemia : a clinico-pathologic study on 24 adult patients. 73
Significato clinico delle alterazioni citogenetiche nelle mielodisplasie studio di 60 pazienti 73
Pathogenetic significance of “pure” monosomy 7 in myeloproliferative disorders. Analyses of 14 cases 73
Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset 72
Severe intestinal vasculitis in a patient under treatment with bortezomib. 72
Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies 72
Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma. 72
Complicanze emorragiche e trombotiche nel paziente chirurgico 72
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. 71
Crioglobulinemie: manifestazioni cliniche 71
Primary dermal melanoma occurring in a patient affected by Philadelphia-positive chronic myeloid leukaemia 71
Carateristiche cliniche peculiari delle leucemie acute monocitiche e loro rilievo prognostico 71
Totale 9.096
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021869 0 0 0 0 0 182 8 197 51 197 198 36
2021/2022905 17 10 30 13 25 43 10 49 46 26 136 500
2022/20232.621 295 169 28 222 328 292 1 168 995 20 78 25
2023/20241.018 98 166 28 88 75 398 11 71 10 18 31 24
2024/20252.367 43 236 70 78 63 55 78 236 515 51 223 719
2025/20262.599 392 426 581 554 540 106 0 0 0 0 0 0
Totale 15.342